Zeitschriftenartikel zum Thema „Mesenchymal stromal cells derivedfrom Wharton's Jelly“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Mesenchymal stromal cells derivedfrom Wharton's Jelly" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Badraiq, H., A. Cvoro, A. Galleu, M. Simon, F. Dazzi und D. Ilic. „Maternal obesity alters characteristics of Wharton's Jelly mesenchymal stromal cells“. Cytotherapy 19, Nr. 5 (Mai 2017): S160. http://dx.doi.org/10.1016/j.jcyt.2017.02.248.
Der volle Inhalt der QuelleLopez-Rodriguez, Y., E. Trevino und M. L. Weiss. „Wharton's jelly mesenchymal stromal cells (WJCs) as immunoregulators in allogeneic transplantation“. Placenta 32 (Oktober 2011): S329. http://dx.doi.org/10.1016/j.placenta.2011.07.040.
Der volle Inhalt der QuelleMajumdar, D., R. Bhonde und I. Datta. „Influence of ischemic microenvironment on human Wharton's Jelly mesenchymal stromal cells“. Placenta 34, Nr. 8 (August 2013): 642–49. http://dx.doi.org/10.1016/j.placenta.2013.04.021.
Der volle Inhalt der QuelleBatsali, A., C. G. Pontikoglou, E. Kouvidi, A. Damianaki, M. Kastrinaki und H. A. Papadaki. „Direct comparison of Wharton's Jelly and bone marrow mesenchymal stem/stromal cells“. Cytotherapy 16, Nr. 4 (April 2014): S73—S74. http://dx.doi.org/10.1016/j.jcyt.2014.01.272.
Der volle Inhalt der QuelleAljitawi, Omar S., Yinghua Xiao, Da Zhang, Lisa Stehno-Bittel, Rama Garimella, Richard A. Hopkins und Michael S. Detamore. „Generating CK19-Positive Cells with Hair-Like Structures from Wharton's Jelly Mesenchymal Stromal Cells“. Stem Cells and Development 22, Nr. 1 (Januar 2013): 18–26. http://dx.doi.org/10.1089/scd.2012.0184.
Der volle Inhalt der QuellePanta, W., H. Kunkanjanawan, T. Kunkanjanawan, R. Parnpai und V. Khemarangsan. „Stability characteristic of cryopreserved human umbilical cord wharton's jelly–derived mesenchymal stromal cells“. Cytotherapy 21, Nr. 5 (Mai 2019): S86. http://dx.doi.org/10.1016/j.jcyt.2019.03.509.
Der volle Inhalt der QuelleMalagon, A., M. Hautefeuille, G. Piñon und A. Castell. „Osteogenic potential of Wharton's jelly mesenchymal stromal cells cultured on a biomimetic scaffold“. Cytotherapy 22, Nr. 5 (Mai 2020): S204—S205. http://dx.doi.org/10.1016/j.jcyt.2020.04.083.
Der volle Inhalt der QuelleDavies, John E., John T. Walker und Armand Keating. „Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells“. STEM CELLS Translational Medicine 6, Nr. 7 (10.05.2017): 1620–30. http://dx.doi.org/10.1002/sctm.16-0492.
Der volle Inhalt der QuelleZhang, Ying-Nan, Pu-Chang Lie und Xing Wei. „Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells“. Cytotherapy 11, Nr. 5 (Januar 2009): 548–58. http://dx.doi.org/10.1080/14653240903051533.
Der volle Inhalt der QuelleLupatov, A. Yu, R. Yu Saryglar, V. D. Chuprynin, S. V. Pavlovich und K. N. Yarygin. „Comparison of the expression profile of surface molecular markers on mesenchymal stromal cell cultures isolated from human endometrium and umbilical cord“. Biomeditsinskaya Khimiya 63, Nr. 1 (Januar 2017): 85–90. http://dx.doi.org/10.18097/pbmc20176301085.
Der volle Inhalt der QuelleDatta, Indrani, Swati Mishra, Lipsa Mohanty, Sunitha Pulikkot und Preeti G. Joshi. „Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells“. Cytotherapy 13, Nr. 8 (September 2011): 918–32. http://dx.doi.org/10.3109/14653249.2011.579957.
Der volle Inhalt der QuelleShohara, Ryutaro, Akihito Yamamoto, Sachiko Takikawa, Akira Iwase, Hideharu Hibi, Fumitaka Kikkawa und Minoru Ueda. „Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms“. Cytotherapy 14, Nr. 10 (September 2012): 1171–81. http://dx.doi.org/10.3109/14653249.2012.706705.
Der volle Inhalt der QuelleGovindasamy, V., M. Chai, Z. Lee, K. Then, S. Cheong und N. Abu Kasim. „Wharton's jelly mesenchymal stromal cells express pancreatic lineage markers upon culturing in hanging drop technique“. Cytotherapy 20, Nr. 5 (Mai 2018): S39. http://dx.doi.org/10.1016/j.jcyt.2018.02.096.
Der volle Inhalt der QuelleManochantr, S., Y. U-pratya, P. Kheolamai, S. Rojphisan, M. Chayosumrit, C. Tantrawatpan, A. Supokawej und S. Issaragrisil. „Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord“. Internal Medicine Journal 43, Nr. 4 (April 2013): 430–39. http://dx.doi.org/10.1111/imj.12044.
Der volle Inhalt der QuelleVivas Pradillo, D., L. Martorell, R. Cabrera-Pérez, C. Mirabel, C. Frago, J. Ayats, M. Monguió-Tortajada et al. „Toward the use of Wharton's Jelly-derived multipotent Mesenchymal Stromal Cells in bone Tissue Engineering strategies“. Cytotherapy 20, Nr. 5 (Mai 2018): S55. http://dx.doi.org/10.1016/j.jcyt.2018.02.152.
Der volle Inhalt der QuelleSV, Konovalov, Moroz VM, Husakova IV, Deryabina OG und Tochilovskyi AA. „Comparative influence of mesenchymal stromal cells of different origin on DNA fragmentation of neuronal nuclei during ischemia-reperfusion of the somatosensory cortex of the rat brain“. Advances in Tissue Engineering & Regenerative Medicine: Open Access 9, Nr. 1 (18.09.2023): 29–33. http://dx.doi.org/10.15406/atroa.2023.09.00138.
Der volle Inhalt der QuelleWu, Li-Fang, Ni-Na Wang, Yuan-Sheng Liu und Xing Wei. „Differentiation of Wharton's Jelly Primitive Stromal Cells into Insulin-Producing Cells in Comparison with Bone Marrow Mesenchymal Stem Cells“. Tissue Engineering Part A 15, Nr. 10 (Oktober 2009): 2865–73. http://dx.doi.org/10.1089/ten.tea.2008.0579.
Der volle Inhalt der QuelleAljitawi, Omar S., Peggy Keefe, Lindsey Ott, Dandan Li, Da Zhang, Sunil Abhyankar, Rama Garimella, Joseph McGuirk und Michael Detamore. „A Wharton's Jelly Mesenchymal Stromal Cell Derived 3D Osteogenic Niche Allows for Cord Blood Stem Cell Attachment“. Blood 118, Nr. 21 (18.11.2011): 4813. http://dx.doi.org/10.1182/blood.v118.21.4813.4813.
Der volle Inhalt der QuelleBalasubramanian, Sudha, Parvathy Venugopal, Swathi Sundarraj, Zubaidah Zakaria, Anish Sen Majumdar und Malancha Ta. „Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells“. Cytotherapy 14, Nr. 1 (Januar 2012): 26–33. http://dx.doi.org/10.3109/14653249.2011.605119.
Der volle Inhalt der QuelleHou, Tianyong, Jianzhong Xu, Xuehui Wu, Zhao Xie, Fei Luo, Zehua Zhang und Ling Zeng. „Umbilical Cord Wharton's Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering“. Tissue Engineering Part A 15, Nr. 9 (September 2009): 2325–34. http://dx.doi.org/10.1089/ten.tea.2008.0402.
Der volle Inhalt der QuellePanta, W., T. Yoisungnern, S. Imsoonthornruksa, S. Suksaweang, M. Ketudat-Cairns und R. Parnpai. „Enhance hepatic differentiation of human Wharton's jelly–derived mesenchymal stromal cells by using sodium butyrate pre-treated“. Cytotherapy 21, Nr. 5 (Mai 2019): S83. http://dx.doi.org/10.1016/j.jcyt.2019.03.499.
Der volle Inhalt der QuelleLopez, Yelica. „Evaluating the Impact of Oxygen Concentration and Plating Density on Human Wharton's Jelly-Derived Mesenchymal Stromal Cells“. Open Tissue Engineering and Regenerative Medicine Journal 4, Nr. 1 (30.12.2011): 82–94. http://dx.doi.org/10.2174/1875043501104010082.
Der volle Inhalt der QuelleCason, Carolina, Giuseppina Campisciano, Nunzia Zanotta, Erica Valencic, Serena Delbue, Ramona Bella und Manola Comar. „SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators“. Journal of Cellular Physiology 232, Nr. 11 (29.12.2016): 3060–66. http://dx.doi.org/10.1002/jcp.25723.
Der volle Inhalt der QuelleChoi, Moran, Hyun-Sun Lee, Purevjargal Naidansaren, Hyun-Kyung Kim, Eunju O, Jung-Ho Cha, Hyun-Young Ahn, Park In Yang, Jong-Chul Shin und Young Ae Joe. „Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels“. International Journal of Biochemistry & Cell Biology 45, Nr. 3 (März 2013): 560–70. http://dx.doi.org/10.1016/j.biocel.2012.12.001.
Der volle Inhalt der QuelleGladysz, D., A. Krzywdzinska, M. Murzyn, K. Kapturska, K. K. Hozyasz und T. Oldak. „The influence of Wharton's jelly-derived mesenchymal stromal cells on T regulatory cells in patients with autism spectrum disorder“. Cytotherapy 20, Nr. 5 (Mai 2018): S97—S98. http://dx.doi.org/10.1016/j.jcyt.2018.02.287.
Der volle Inhalt der QuelleFrausin, Stefano, Serena Viventi, Lucia Verga Falzacappa, Miriana Jlenia Quattromani, Giampiero Leanza, Alberto Tommasini und Erica Valencic. „Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research“. Acta Histochemica 117, Nr. 4-5 (Mai 2015): 329–38. http://dx.doi.org/10.1016/j.acthis.2015.02.005.
Der volle Inhalt der QuelleNajar, Mehdi, Gordana Raicevic, Hicham Id Boufker, Hussein Fayyad-Kazan, Cécile De Bruyn, Nathalie Meuleman, Dominique Bron, Michel Toungouz und Laurence Lagneaux. „Adipose-Tissue-Derived and Wharton's Jelly–Derived Mesenchymal Stromal Cells Suppress Lymphocyte Responses by Secreting Leukemia Inhibitory Factor“. Tissue Engineering Part A 16, Nr. 11 (November 2010): 3537–46. http://dx.doi.org/10.1089/ten.tea.2010.0159.
Der volle Inhalt der QuelleOliver-Vila, Irene, Maria Isabel Coca, Marta Grau-Vorster, Noèlia Pujals-Fonts, Marta Caminal, Alba Casamayor-Genescà, Isabel Ortega et al. „Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly“. Cytotherapy 18, Nr. 1 (Januar 2016): 25–35. http://dx.doi.org/10.1016/j.jcyt.2015.10.001.
Der volle Inhalt der QuelleBoey, K. P., D. S. Lim, C. Ong, J. Mesilamani, K. Tang, M. Li, P. Zhu und T. T. Phan. „Comparison of extraction methods and culture medium for umbilical cord lining- and wharton's jelly-derived mesenchymal stromal cells“. Cytotherapy 21, Nr. 5 (Mai 2019): S80. http://dx.doi.org/10.1016/j.jcyt.2019.03.489.
Der volle Inhalt der QuelleHang, Zhao, und Xiao Haijun. „Proliferative, Differentiative, and Immunological Characteristics of Chondro-Differentiated Mesenchymal Stromal Cells Derived from Rabbit Umbilical Cord Wharton's Jelly“. Journal of Biomaterials and Tissue Engineering 8, Nr. 7 (01.07.2018): 1046–52. http://dx.doi.org/10.1166/jbt.2018.1833.
Der volle Inhalt der QuelleLee, Hyun-Sun, Kwang S. Kim, Hee-Suk Lim, Moran Choi, Hyun-Kyung Kim, Hyun-Young Ahn, Jong-Chul Shin und Young Ae Joe. „Priming Wharton's Jelly-Derived Mesenchymal Stromal/Stem Cells With ROCK Inhibitor Improves Recovery in an Intracerebral Hemorrhage Model“. Journal of Cellular Biochemistry 116, Nr. 2 (12.12.2014): 310–19. http://dx.doi.org/10.1002/jcb.24969.
Der volle Inhalt der QuelleSharma, Tulika, Poonam Kumari, Neha Pincha, Naresh Mutukula, Shekhar Saha, Siddhartha S. Jana und Malancha Ta. „Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells“. Cytotherapy 16, Nr. 5 (Mai 2014): 640–52. http://dx.doi.org/10.1016/j.jcyt.2013.09.003.
Der volle Inhalt der QuelleOppliger, Byron, Marianne S. Joerger-Messerli, Cedric Simillion, Martin Mueller, Daniel V. Surbek und Andreina Schoeberlein. „Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact“. Cytotherapy 19, Nr. 7 (Juli 2017): 829–38. http://dx.doi.org/10.1016/j.jcyt.2017.03.075.
Der volle Inhalt der QuelleMilazzo, Luisa, Francesca Vulcano, Alessandra Barca, Giampiero Macioce, Emanuela Paldino, Stefania Rossi, Carmela Ciccarelli, Hamisa J. Hassan und Adele Giampaolo. „Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice“. European Journal of Haematology 93, Nr. 5 (26.05.2014): 384–91. http://dx.doi.org/10.1111/ejh.12363.
Der volle Inhalt der QuelleBatsali, Aristea, Charalampos Pontikoglou, Elisavet Kouvidi, Athina Damianaki, Aikaterini Stratigi, Maria-Christina Kastrinaki und Helen A. Papadaki. „Comparative Analysis Of Bone Marrow and Wharton’s Jelly Mesenchymal Stem/Stromal Cells“. Blood 122, Nr. 21 (15.11.2013): 1212. http://dx.doi.org/10.1182/blood.v122.21.1212.1212.
Der volle Inhalt der QuelleBatsali, Aristea, Charalampos Pontikoglou, Emmanuel Agrafiotis, Elisavet Kouvidi, Irene Mavroudi, Athina Damianaki, Maria-Christina Kastrinaki und Helen Papadaki. „Emerging Roles of Wisp-1 and SFRP4 in Proliferation and Differentiation Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells“. Blood 124, Nr. 21 (06.12.2014): 4375. http://dx.doi.org/10.1182/blood.v124.21.4375.4375.
Der volle Inhalt der QuelleDe Bruyn, Cécile, Mehdi Najar, Gordana Raicevic, Nathalie Meuleman, Karlien Pieters, Basile Stamatopoulos, Alain Delforge, Dominique Bron und Laurence Lagneaux. „A Rapid, Simple, and Reproducible Method for the Isolation of Mesenchymal Stromal Cells from Wharton's Jelly Without Enzymatic Treatment“. Stem Cells and Development 20, Nr. 3 (März 2011): 547–57. http://dx.doi.org/10.1089/scd.2010.0260.
Der volle Inhalt der QuelleQuaranta, Paola, Daniele Focosi, Marilena Di Iesu, Chiara Cursi, Alessandra Zucca, Michele Curcio, Simone Lapi et al. „Human Wharton's jelly–derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties“. Cytotherapy 18, Nr. 2 (Februar 2016): 205–18. http://dx.doi.org/10.1016/j.jcyt.2015.11.011.
Der volle Inhalt der QuelleColl, R., J. Vidal, H. Kumru, J. Benito, M. Valles, N. Ribó, M. Codinach et al. „Intrathecal administration of expanded wharton's jelly mesenchymal stromal cells (WJ-MSC) in chronic traumatic spinal cord injury (SCI) (NCT03003364)“. Cytotherapy 20, Nr. 5 (Mai 2018): S33—S34. http://dx.doi.org/10.1016/j.jcyt.2018.02.082.
Der volle Inhalt der QuelleColl, R., J. Vidal, H. Kumru, J. Benito, M. Valles, M. Codinach, M. Blanco et al. „Is HLA matching relevant for treating Spinal Cord Injury with intrathecal administration of expanded Wharton's Jelly Mesenchymal Stromal Cells?“ Cytotherapy 22, Nr. 5 (Mai 2020): S26—S27. http://dx.doi.org/10.1016/j.jcyt.2020.03.006.
Der volle Inhalt der QuelleFernández, A. López, I. Carreras Sánchez und J. Vives. „Successful scale up expansion of Wharton's jelly mesenchymal stromal cells in different commercial xeno-free and serum-free media“. Cytotherapy 22, Nr. 5 (Mai 2020): S94. http://dx.doi.org/10.1016/j.jcyt.2020.03.162.
Der volle Inhalt der QuellePochon, Cecile, Romain Perouf, Allan Bertrand, Anne-Béatrice Notarantonio, Naceur Charif, Marcelo De Carvalho Bittencourt, Guillemette Fouquet et al. „IFN-γ Primed Wharton's Jelly Mesenchymal Stromal Cells Inhibit T Cell Proliferation By Synergistic IDO and Mitochondrial Transfer Mechanisms“. Blood 140, Supplement 1 (15.11.2022): 4504–5. http://dx.doi.org/10.1182/blood-2022-167814.
Der volle Inhalt der QuelleKaushik, Komal, und Amitava Das. „Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly–mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair“. Cytotherapy 21, Nr. 2 (Februar 2019): 260–73. http://dx.doi.org/10.1016/j.jcyt.2019.01.004.
Der volle Inhalt der QuelleWang, Ying, Feng Chen, Bing Gu, Guanghua Chen, Huirong Chang und Depei Wu. „Mesenchymal Stromal Cells as an Adjuvant Treatment for Severe Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation“. Acta Haematologica 133, Nr. 1 (16.08.2014): 72–77. http://dx.doi.org/10.1159/000362530.
Der volle Inhalt der QuelleJing, Bai, Hu Yuan, Wang Yi-Ru, Liu Li-Feng, Chen Jie, Su Shao-Ping und Wang Yu. „Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity“. Journal of Geriatric Cardiology 9, Nr. 2 (20.07.2012): 166–71. http://dx.doi.org/10.3724/sp.j.1263.2011.12091.
Der volle Inhalt der QuelleBai, Jing, und Yu Wang. „COMPARISON OF HUMAN AMNIOTIC FLUID-DERIVED AND UMBILICAL CORD WHARTON'S JELLY-DERIVED MESENCHYMAL STROMAL CELLS: CHARACTERISATION AND MYOCARDIAL DIFFERENTIATION CAPACITY“. Heart 98, Suppl 2 (Oktober 2012): E67.3—E68. http://dx.doi.org/10.1136/heartjnl-2012-302920a.167.
Der volle Inhalt der Quellevan der Garde, Mark, Melissa van Pel, Jose Eduardo Millán Rivero, Alice de Graaf-Dijkstra, Manon C. Slot, Yoshiko Kleinveld, Suzanne M. Watt, Helene Roelofs und Jaap Jan Zwaginga. „Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34+Transplants“. Stem Cells and Development 24, Nr. 22 (15.11.2015): 2649–59. http://dx.doi.org/10.1089/scd.2015.0138.
Der volle Inhalt der QuelleMoreira, Alvaro, Caitlyn Winter, Jooby Joy, Lauryn Winter, Maxwell Jones, Michelle Noronha, Melissa Porter et al. „Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia“. STEM CELLS Translational Medicine 9, Nr. 2 (27.11.2019): 221–34. http://dx.doi.org/10.1002/sctm.18-0273.
Der volle Inhalt der QuelleVulcano, Francesca, Luisa Milazzo, Carmela Ciccarelli, Adriana Eramo, Giovanni Sette, Annunziata Mauro, Giampiero Macioce et al. „Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer“. Experimental Cell Research 345, Nr. 2 (Juli 2016): 190–98. http://dx.doi.org/10.1016/j.yexcr.2016.06.003.
Der volle Inhalt der Quellevan der Garde, Mark, Melissa Van Pel, Jose Millan Rivero, Alice de Graaf-Dijkstra, Manon Slot, Yoshiko Kleinveld, Suzanne Watt, Helene Roelofs und Jaap Jan Zwaginga. „Direct Comparison of Wharton Jelly and Bone Marrow Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34+ Transplants“. Blood 126, Nr. 23 (03.12.2015): 5410. http://dx.doi.org/10.1182/blood.v126.23.5410.5410.
Der volle Inhalt der Quelle